Know Labs

Know Labs is a pioneering company in the field of non-invasive medical diagnostics, specializing in blood glucose monitoring. The company holds over 270 patents related to its BIO RFID technology, which allows for non-invasive continuous glucose monitoring (CGM). Know Labs is currently in the process of obtaining FDA clearance for its KnowU wearable device, which, once approved, will be the first of its kind in a $21 billion global market. The company serves individuals with diabetes and healthcare providers, offering a revolutionary way to monitor blood glucose levels without the need for traditional invasive methods. Know Labs operates in the healthcare technology market and employs a business model focused on intellectual property and product development. Revenue is generated through the commercialization of its patented technologies and future sales of its FDA-approved devices. The company benefits from a highly experienced management team and board, including experts in sensor technology, optoelectronics, and commercial development. Key figures include Chris, who has a 40-year career in innovation commercialization, and Donna Ryan, a former President of the American Association of Diabetes Educators.

Keywords: non-invasive, blood glucose monitoring, BIO RFID, FDA clearance, healthcare technology, diabetes management, intellectual property, continuous glucose monitoring, wearable device, sensor technology.